Table 2.
US Cancer Death Rate Trends With Joinpoint Analyses From 1975 to 2010 for the Most Common Cancers, by Sex, for All Racial and Ethnic Groups Combineda
Joinpoint analyses (1975-2010)b |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trend 1 |
Trend 2 |
Trend 3 |
Trend 4 |
Trend 5 |
Trend 6 |
AAPCc |
||||||||
Sex/Cancer Site or Type |
Years | AP Cd |
Years | APC d |
Years | APC d |
Years | APC d |
Years | AP Cd |
Years | AP Cd |
2001 - 2010 |
2006 - 2010 |
All sites | ||||||||||||||
Both sexes | 1975 - 1984 |
0.5 e | 1984 - 1991 |
0.3 e | 1991 - 1994 |
−0.5 | 1994 - 1998 |
−1.3 e | 1998 - 2001 |
−0.8 | 2001 - 2010 |
−1.5 e | −1.5 f | − 1.5 f |
Males | 1975 - 1979 |
1.0 e | 1979 - 1990 |
0.3 e | 1990 - 1993 |
−0.5 | 1993 - 2001 |
−1.5 e | 2001 - 2010 |
−1.8 e | −1.8 f | − 1.8 f |
||
Females | 1975 - 1990 |
0.6 e | 1990 - 1994 |
−0.2 | 1994 - 2002 |
−0.8 e | 2002 - 2010 |
−1.4 e | −1.4 f | − 1.4 f |
||||
Children (ages 0-14) |
1975 - 1998 |
−2.9 e | 1998 - 2003 |
0.2 | 2003 - 2010 |
−2.4 e | −1.9 f | − 2.4 f |
||||||
Children (ages 0-19) |
1975 - 1998 |
−2.7 e | 1998 - 2002 |
0.3 | 2002 - 2010 |
−2.4 e | −2.1 f | − 2.4 f |
||||||
Top 17 cancers for malesg |
||||||||||||||
Lung and bronchus |
1975 - 1978 |
2.5 e | 1978 - 1984 |
1.2 e | 1984 - 1990 |
0.4 e | 1990 - 1993 |
−1.1 | 1993 - 2005 |
−1.9 e | 2005 - 2010 |
−2.9 e | −2.5 f | − 2.9 f |
Prostate | 1975 - 1987 |
0.9 e | 1987 - 1991 |
3.1 e | 1991 - 1994 |
−0.8 | 1994 - 2004 |
−3.8 e | 2004 - 2010 |
−3.1 e | −3.3 f | − 3.1 f |
||
Colon and rectum |
1975 - 1978 |
0.8 | 1978 - 1985 |
−0.4 e | 1985 - 1990 |
−1.4 e | 1990 - 2002 |
−2.0 e | 2002 - 2005 |
−4.0 e | 2005 - 2010 |
−2.5 e | −2.9 f | − 2.5 f |
Pancreas | 1975 - 1986 |
−0.8 e | 1986 - 2001 |
−0.3 e | 2001 - 2010 |
0.5 e | 0.5 f | 0.5 f | ||||||
Leukemia | 1975 - 1980 |
0.5 | 1980 - 1987 |
−0.7 e | 1987 - 1995 |
0.1 | 1995 - 2010 |
−0.9 e | −0.9 f | − 0.9 f |
||||
Liver and intrahepatic bile duct |
1975 - 1985 |
1.5 e | 1985 - 1996 |
3.8 e | 1996 - 1999 |
0.5 | 1999 - 2010 |
2.5 e | 2.5 f | 2.5 f | ||||
Non-Hodgkin lymphoma |
1975 - 1996 |
2.5 e | 1996 - 2010 |
−2.6 e | −2.6 f | − 2.6 f |
||||||||
Urinary bladder | 1975 - 1983 |
−1.4 e | 1983 - 1987 |
−2.8 e | 1987 - 1993 |
0.2 | 1993 - 1997 |
−1.1 | 1997 - 2010 |
0.1 | 0.1 | 0.1 | ||
Esophagus | 1975 - 1985 |
0.7 e | 1985 - 1994 |
1.2 e | 1994 - 2005 |
0.4 e | 2005 - 2010 |
−1.1 e | −0.4 f | − 1.1 f |
||||
Kidney and renal pelvis |
1975 - 1991 |
1.1 e | 1991 - 2001 |
−0.1 | 2001 - 2010 |
−0.9 e | −0.9 f | − 0.9 f |
||||||
Brain and other nervous system |
1975 - 1977 |
4.4 | 1977 - 1982 |
−0.4 | 1982 - 1991 |
1.3 e | 1991 - 2007 |
−1.0 e | 2007 - 2010 |
0.7 | −0.4 | 0.3 | ||
Stomach | 1975 - 1987 |
−2.4 e | 1987 - 1990 |
−0.3 | 1990 - 2010 |
−3.4 e | −3.4 f | − 3.4 f |
||||||
Myeloma | 1975 - 1994 |
1.5 e | 1994 - 2010 |
−1.1 e | −1.1 f | − 1.1 f |
||||||||
Melanoma of the skin |
1975 - 1989 |
2.2 e | 1989 - 2010 |
0.3 e | 0.3 f | 0.3 f | ||||||||
Oral cavity and pharynx |
1975 - 1993 |
−1.9 e | 1993 - 2000 |
−3.0 e | 2000 - 2010 |
−1.2 e | −1.2 f | − 1.2 f |
||||||
Larynx | 1975 - 1994 |
−0.8 e | 1994 - 2010 |
−2.5 e | −2.5 f | − 2.5 f |
||||||||
Soft tissue including heart |
1975 - 1980 |
7.6 e | 1980 - 1997 |
1.2 e | 1997 - 2002 |
−3.6 e | 2002 - 2010 |
1.4 e | 0.8 f | 1.4 f | ||||
Top 18 cancers for femalesg |
||||||||||||||
Lung and bronchus |
1975 - 1982 |
6.0 e | 1982 - 1990 |
4.2 e | 1990 - 1995 |
1.7 e | 1995 - 2004 |
0.3 e | 2004 - 2010 |
−1.4 e | −0.8 f | −1.4 f | ||
Breast | 1975 - 1990 |
0.4 e | 1990 - 1995 |
−1.8 e | 1995 - 1998 |
−3.2 e | 1998 - 2010 |
−1.9 e | −1.9 f | − 1.9 f |
||||
Colon and rectum |
1975 - 1984 |
−1.0 e | 1984 - 2001 |
−1.8 e | 2001 - 2010 |
−2.9 e | −2.9 f | − 2.9 f |
||||||
Pancreas | 1975 - 1984 |
0.8 e | 1984 - 2002 |
0.1 | 2002 - 2010 |
0.5 e | 0.4 f | 0.5 f | ||||||
Ovary | 1975 - 1982 |
−1.2 e | 1982 - 1992 |
0.3 e | 1992 - 1998 |
−1.2 e | 1998 - 2002 |
1.0 | 2002 - 2010 |
−1.9 e | −1.6 f | − 1.9 f |
||
Leukemia | 1975 - 1980 |
0.8 | 1980 - 2000 |
−0.4 e | 2000 - 2010 |
−1.3 e | −1.3 f | − 1.3 f |
||||||
Non-Hodgkin lymphoma |
1975 - 1994 |
2.2 e | 1994 - 1997 |
0.9 | 1997 - 2010 |
−3.2 e | −3.2 f | − 3.2 f |
||||||
Corpus and uterus, NOS |
1975 - 1989 |
−1.6 e | 1989 - 1997 |
−0.7 e | 1997 - 2010 |
0.4 e | 0.4 f | 0.4 f | ||||||
Brain and other nervous system |
1975 - 1992 |
0.9 e | 1992 - 2010 |
−0.9 e | −0.9 f | − 0.9 f |
||||||||
Liver and intrahepatic bile duct |
1975 - 1987 |
0.8 e | 1987 - 1995 |
3.8 e | 1995 - 2000 |
0.3 | 2000 - 2010 |
1.6 e | 1.6 f | 1.6 f | ||||
Myeloma | 1975 - 1993 |
1.5 e | 1993 - 2001 |
−0.4 | 2001 - 2010 |
−2.3 e | −2.3 f | − 2.3 f |
||||||
Kidney and renal pelvis |
1975 - 1994 |
1.1 e | 1994 - 2010 |
−0.9 e | −0.9 f | − 0.9 f |
||||||||
Stomach | 1975 - 1987 |
−2.8 e | 1987 - 1990 |
−0.4 | 1990 - 2010 |
−2.7 e | −2.7 f | −2.7 f | ||||||
Cervix uteri | 1975 - 1982 |
−4.3 e | 1982 - 1996 |
−1.6 e | 1996 - 2003 |
−3.7 e | 2003 - 2010 |
−1.1 e | −1.7 f | − 1.1 f |
||||
Urinary bladder | 1975 - 1986 |
−1.7 e | 1986 - 2010 |
−0.4 e | −0.4 f | − 0.4 f |
||||||||
Esophagus | 1975 - 2000 |
0.1 | 2000 - 2010 |
−1.5 e | −1.5 f | −1.5 f | ||||||||
Oral cavity and pharynx |
1975 - 1990 |
−0.9 e | 1990 - 2005 |
−2.4 e | 2005 - 2010 |
−0.9 | −1.6 f | − 0.9 |
||||||
Gallbladder | 1975 - 2002 |
−2.7 e | 2002 - 2010 |
−1.2 e | −1.3 f | − 1.2 f |
Abbreviations: AAPC, average annual percent change; APC, annual percent change; NOS, not otherwise specified.
Source: National Center for Health Statistics public-use data file for the total US, 1975 through 2010.
Joinpoint analyses with up to 5 joinpoints yielding up to 6 trend segments (Trends 1-6) were based on rates per 100,000 persons and were age-adjusted to the 2000 US standard population (19 age groups:ages <1 year, 1-4 years, 5-9 years, …, 80-84 years, ≥85 years; Census publication p25-1130; US Bureau of the Census, Current Population Reports, p25-1130. Washington, DC: US Government Printing Office, 2000). For joinpoint analysis, the Joinpoint Regression Program was used (version 4.0.3, April 2013; Surveillance Research Program, National Cancer Institute, Bethesda, Md).
The AAPC is a weighted average of the APCs calculated by joinpoint regression.
The APC is based on rates that were age-adjusted to the 2000 U.S. standard population (19 age groups: ages <1 year, 1-4 years, 5-9 years, …, 80-84 years, and 85 years; Census publication p25-1130).
The APC is statistically significantly different from zero (2-sided t test; P <.05).
The AAPC is statistically significantly different from zero (2-sided Z test; P <.05).
Cancers are listed in descending rank order of sex-specific, age-adjusted incidence rates for 2006 through 2010 for all racial and ethnic groups combined. More than 15 cancers may appear under men and women to include the top 15 cancers in each racial and ethnic group.